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Jong-Won Ha and Chi Young Shim*
Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, South Korea
Background: Patients who underwent permanent pacemaker (PM) implantation have
a potential risk of left ventricular (LV) systolic dysfunction. However, assessment of
LV ejection fraction (LVEF) shows a limited role in identifying subclinical LV systolic
dysfunction and predicting cardiovascular (CV) outcomes.
Methods: We reviewed 1,103 patients who underwent permanent PM implantation
between January 2007 and December 2017. After excluding patients who did not
undergo echocardiograms before or after PM implantation and those with LV ejection
fraction (LVEF) <50%, significant valve dysfunction, and history of cardiac surgery before
PM implantation, 300 (67 ± 13 years, 119 men) were finally analyzed. LV mechanical
function was assessed with LV global longitudinal strain (LV-GLS) using 2-dimensional
speckle-tracking echocardiography. CV outcomes were defined as a composite of CV
death and hospitalization for heart failure.
Results: At 44 ± 28 months after post-PM echocardiogram, 23 patients (7.7%)
had experienced CV outcomes. Patients with CV outcomes were older and had more
comorbidities and a lower baseline |LV-GLS| than those without CV outcomes. LV
mechanical function worsened after PM implantation in patients with CV outcomes. The
cut-off value of 11.2% in |LV-GLS| on post-PM echocardiogram had a better predictive
value for CV outcomes (AUC; 0.784 vs. 0.647, p = 0.012). CV outcome in patients
with |LV-GLS|<11.2% was worse than that in those with |LV-GLS| ≥ 11.2% (log-rank
p <0.001). Multivariate Cox model revealed that reduced |LV-GLS| was independently
associated with CV outcomes.
Conclusions: Pacing deteriorates LV mechanical function. Impaired LV-GLS is
associated with poor CV outcomes in patients who underwent PM implantation.
Keywords: pacemaker, left ventricular global longitudinal strain, left ventricular ejection fraction (LVEF),
cardiomyopahty, outcome
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INTRODUCTION
Patients who have undergone permanent pacemaker (PM)
implantation have a potential risk of left ventricular (LV)
systolic dysfunction (1–3). PM-induced cardiomyopathy
(PMIC) is generally defined as a decrease in LV systolic
function after right ventricular (RV) pacing with no other
independent triggering factors (4) and is associated with worse
cardiovascular (CV) outcomes (5). Theoretically, increasing RV
pacing causes LV mechanical dyssynchrony and consequently
leads to a decrease in LV ejection fraction (LVEF) and CV
events related to worsening heart failure (6–8). Although
LVEF is the most widely used echocardiographic parameter
representing LV systolic function, its measurement can be less
reliable in patients with PM because of LV dyssynchronous
contraction (9). Moreover, assessment of LVEF shows a
limited role in identifying subclinical LV systolic dysfunction,
both in patients at risk of PMIC and in the early stages
of PMIC.
Assessment of LV mechanical function using LV-global
longitudinal strain (LV-GLS) by 2-dimensional speckle-tracking
echocardiography can detect subclinical LV dysfunction in
the early stages of cardiomyopathy to provide prognostic
information (10–12). A previous study demonstrated that
LV-GLS could provide better risk stratification than could
LVEF among patients with LV dyssynchrony caused by
left bundle branch block (13). Therefore, we hypothesized
that there would be a significant relationship between LV-
GLS measured by 2D speckle-tracking echocardiography




A total of 1,103 patients who underwent permanent PM
implantation at a single tertiary hospital between January 2007
and December 2017 was identified retrospectively. Among
them, we selected patients who underwent both baseline
transthoracic echocardiography within 1 year before PM
implantation and follow-up echocardiography between 6
months and 5 years after PM implantation. We excluded
patients who had overt LV systolic dysfunction (LVEF <50%)
before PM implantation, had at least a moderate degree of
any valve dysfunction on baseline echocardiography, had a
history of cardiac surgery, acute myocardial infarction within
3 months before PM implantation, and single-lead right atrial
PM. All patients who had cardiovascular events in time between
baseline and post-implantation echocardiogram were also
excluded from this study cohort. Finally, 300 patients were
included in the analysis. Patients’ clinical data, medications,
PM characteristics, echocardiographic characteristics, and
clinical outcomes were reviewed retrospectively. The
study was approved by the Institutional Review Board of
Yonsei University Health System (approval number: 4-
2020-0032) and conducted according to the Declaration
of Helsinki.
Follow-Up and Outcomes
Patients were scheduled to visit the PM clinic every 6
months after PM implantation. Follow-up data, including pacing
percentage and clinical events, were obtained by reviewing
medical records. Data of pacing percentage was gathered at the
time of the first interrogation after 2 months of PM implantation.
Based on the echocardiographic data between 6 months and
5 years after PM implantation, PMIC was defined as a ≥10%
decrease in LVEF compared with baseline echocardiography with
resultant LVEF<50% (14). We reviewed all medical records after
PM implantation through total follow-up periods, and patients
who had an event of myocardial infarction, acute coronary
syndrome, and who had severe valvular stenosis/regurgitation
on post-PM echocardiogram were excluded from later analysis.
CV outcomes were defined as a composite of admission for
heart failure and CV death and the event was included only
after the time of post-PM echocardiography. Admission of heart
failure was defined when following conditions were met: the
patient’s symptom of dyspnea at least 3 of New York Heart
Association (NYHA) class, required medication such as diuretics
or vasodilators, elevatedN-terminal pro-brain natriuretic peptide
(NT-proBNP), and pulmonary edema or pleural effusion in chest
X-ray. CV death was defined as the cause of the death was
acute myocardial infarction, heaft failure, sudden cardiac death,
lethal ventricular arrhythmia, or stroke, and we determined the
CV death by review the patient’s medical record and the death
certificate. If a patient had at least two clinical outcomes, the first
event was included for outcome analyses.
Echocardiography
Standard 2D and Doppler measurements were performed using
a standard ultrasound machine (Vivid E9; GE Medical Systems,
Chicago, IL; Philips iE33; Philips Healthcare, Netherlands) with a
2.5–3.5 MHz probe. Standard echocardiographic measurements
were performed according to recommendations from the
European association of cardiovascular imaging (15). LVEF was
measured using the biplane Simpson’s method in apical four- and
two-chamber views. Left atrial volume index wasmeasured by the
biplane method in both the apical four- and two-chamber views
and indexed on the body surface area. The severity of tricuspid
regurgitation was graded with multi-parametric methods. (16).
Speckle-Tracking Echocardiography
The two-dimensional images from both baseline echocardiogram
and echocardiogram after PM implantation were used for
analyses of LV mechanical function. Three apical four-, three-,
and two-chamber images for each echocardiographic study
were stored and exported to the off-line data storage device,
and speckle-tracking echocardiography was performed using a
vendor-independent software package (TomTec software; Image
Arena 4.6, Munich, Germany) as described previously (17).
After that, LV-GLS and segmental longitudinal strain values
were measured in a blinded method from the clinical data by
experienced cardiologists, according to the practical guidance
in assessing strain (18, 19). LV endocardial borders were traced
at the end-diastolic and end-systolic frames in each apical
view. TomTec software tracked the speckle on three endocardial
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FIGURE 1 | Representative LV-GLS measurements. (A) LV-GLS was calculated from three standard apical views at baseline echocardiogram (left). The absolute value
of LV-GLS was 23.0% (right). (B) LV-GLS was assessed after PM implantation. |LV-GLS| was 14.8% (right). LV-GLS, left ventricular global longitudinal strain;
PM, pacemaker.
borders during the whole cardiac cycle. For analysis of segmental
strain, we used the 16-segment model that divided the base and
mid area into six segments (antero-septum, anterior, antero-
lateral, infero-lateral, inferior, and infero-septal) and the apex
into four segments (septal, inferior, lateral, and anterior), and LV-
GLS was calculated by averaging the values at each segmental
level as mentioned above. |LV-GLS| was defined as the absolute
value of LV-GLS (removing the conventional negative value of
LV-GLS data) (Figure 1). The LV-global circumferential strain
(GCS) was calculated by averaging the values of segmental
circumferential strains from the parasternal short-axis view in
the basal-, mid-, and apical-LV levels. |LV-GLS| was defined
as the absolute value of LV-GCS. We randomly selected 20
patients from the study population and analyzed the intra-
and inter-observer reproducibility of LV-GLS measurement by
Bland–Altman analysis. The intra-class correlation coefficients
for |LV-GLS| were 0.987 and 0.963 for intra- and inter-observer
variation, respectively. The Bland–Altman analysis showed the
limits of agreement (LOA) across a broad range of LV-GLS
values; the bias for intra- and inter-observermeasurements of LV-
GLS was 0.47% (range: −0.91 to −0.04%, 95% LOA) and 0.37%
(range:−0.71 to 0.78%), respectively.
Statistical Analysis
Continuous variables are presented as mean ± standard
deviation (SD), and categorical variables are presented as
frequency and percentage. Comparisons of baseline clinical
and echocardiographic parameters between the two groups
were analyzed using Student’s t-test for continuous data and
chi-square (χ2) and Fisher’s exact test for categorical data.
Correlations between pacing percentage and echocardiographic
variables including the strain of each segment were obtained
using simple linear regression analysis and multiple linear
regression analysis for adjusting other confounding factors.
Predictive values of LV-GLS for CV outcomes were calculated
using receiver operating characteristic (ROC) analysis. Clinical
outcomes were constructed using Kaplan–Meier methods, and
comparisons among groups were performed using a log-
rank test. The predictors of CV outcomes were evaluated
using multivariate nested Cox proportional hazard regression
models. The independence of |LV-GLS| was examined using
three models. Initially, three subgroups divided by |LV-GLS|
tertile were included in the Cox model as a covariate, with
adjustment for age and sex. Then, chronic kidney disease and
coronary artery disease were included in the second model.
Finally, LVEF and left atrial volume index were included in
the last model. Significant differences were considered at P <
0.05. All statistical analyses were performed using SPSS 25.0
software (IBM Corp., Armonk, NY), and Medcalc statistical
package (Medcalc software, Mariakerke, Belgium) was used for
comparison of ROC curves.
RESULTS
Baseline Characteristics
During a mean 44 ± 28 months of follow-up after post-PM
echocardiography, 23 of 300 patients (7.7%) experienced
CV events. Clinical characteristics, medications, and data
related to PM in patients with or without CV outcomes
are presented in Table 1. Patients with CV outcomes were
older and had a higher prevalence of chronic kidney
disease, coronary artery disease than did those without CV
outcomes. More heart failure medications including renin-
angiotensin-aldosterone system blockade and diuretics
were used by patients with CV outcomes compared
to those without CV outcomes. The ventricular lead
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TABLE 1 | Baseline characteristics.
Total (n = 300) Without CV outcomes (n =277) With CV outcomes (n = 23) P-value
Age, years 67.1 ± 13.2 66.2 ± 13.8 74.5 ± 9.9 0.005
Male sex, n (%) 119 (39.7) 107 (38.6) 12 (52.2) 0.202
BMI, kg/m2 24.3 ± 3.6 24.3 ± 3.6 25.0 ± 3.6 0.357
Hypertension, n (%) 171 (57.0) 155 (56.0) 16 (69.6) 0.205
Diabetes mellitus, n (%) 61 (20.3) 54 (19.5) 7 (30.4) 0.210
CKD, n (%) 22 (7.3) 16 (5.8) 6 (26.1) <0.001
AF, n (%) 54 (18.0) 48 (17.3) 6 (26.1) 0.293
CAD, n (%) 39 (13.0) 30 (10.8) 9 (39.1) <0.001
HFpEF, n (%) 5 (1.7) 4 (1.4) 1 (4.3) 0.296
Medications, n (%)
RAAS blockers 141 (47.0) 122 (44.0) 19 (82.6) <0.001
Beta blockers 39 (13.0) 36 (13.0) 3 (13.0) 0.995
CCB 69 (23.0) 64 (23.1) 5(21.7) 0.881
Diuretics 78 (26.0) 68 (24.5) 10 (43.5) 0.047
Statin 89 (29.7) 81 (29.2) 8 (34.8) 0.576
V lead position, n (%)
Apex 273 (91.0) 250 (90.3) 23 (100.0) 0.117
Septum 27 (9.0) 27 (9.7) 0 (0.0)
Pacing percentage, % 60.4 ± 42.4 61.3 ± 42.3 49.7 ± 42.6 0.211
CV, cardiovascular; BMI, body mass index; CKD, chronic kidney disease; AF, atrial fibrillation; CAD, coronary artery disease; HFpEF, heart failure with preserved ejection fraction; RAAS,
renin-angiotensin-aldosterone system; CCB, calcium channel blockers; V, ventricular.
position and pacing percentage were not different between
the groups.
Baseline and post-PM echocardiographic variables are
presented in Table 2. On baseline echocardiogram, patients
with CV outcomes showed lower e’ and S’ velocities, higher E/e’,
and lower |LV-GLS| than did those without CV outcomes. On
post-PM echocardiogram, more dilated chambers, relatively
low LVEF (even though mean LVEF was within the normal
range), higher LV mass index, lower S’ velocity, higher E/e’, and
lower |LV-GLS| and |LV-GCS| were shown in patients with CV
outcomes compared to patients without CV outcomes. Timing
of post-PM echocardiogram after PM implantation was not
different between the groups.
Relationship Between RV Pacing and LV
Mechanical Dysfunction
The correlations between RV pacing percentage on the first
PM interrogation results and the parameters on post-PM
echocardiogram are presented in Table 3. As RV pacing
percentage increased, functional and structural deterioration was
observed. The correlation between RV pacing percentage and
|LV-GLS| was significant (r = 0.257, p < 0.001) compared to that
of other global functional parameters and this phenomenon was
strengthened especially with RV apical pacing, compared with RV
septal pacing (p < 0.001 vs. p= 0.248). In terms of LV segmental
strain, RV pacing percentage was significantly associated with
impaired strain at all segments in the LV apex and at inferior and
septal segments in themid-LV.Multiple linear regression analysis
revealed that RV pacing percentage was independently associated
with impaired |LV-GLS| and |Apical septal strain| after adjusting
for age, sex, HTN, and DM in all the study subjects (both p <
0.001) (Supplementary Table 1). When compared the subgroup
with RV pacing percentage divided by 50%, the subgroup with the
RV pacing under 50% had better event-free survival than those
who were not (log rank p= 0.047) (Supplementary Figure 1).
Occurrence of PMIC and CV Outcomes
Based on LV-GLS Levels
The changes in LVEF and |LV-GLS| according to the CV
outcomes at the baseline echocardiogram and post-PM follow-up
study are shown in Figure 2. LVEF and |LV-GLS| were decreased
after PM implantation in the groupwithout CV outcomes and the
group with CV outcomes. However, LVEF after PM implantation
maintained normal values in both groups, whereas |LV-GLS|
decreased more noticeably in patients with CV outcomes. When
compared the subgroup which was divided by the degree of |LV-
GLS| change, the subgroup with the |LV-GLS| reduction under
10% had better event-free survival than those who were not (log
rank p= 0.035) (Supplementary Figure 2).
ROC analysis of predictive values of LVEF and |LV-GLS| for
PMIC and CV outcomes are shown in Figure 3. The |LV-GLS|
on baseline echocardiogram revealed a significant predictive
value for PMIC (area under the curve, AUC: 0.622, p = 0.024,
cut-off 21.4%, sensitivity 81.3%, specificity 53.7%) after PM
implantation. In terms of CV outcomes, the cut-off value of
11.2% in |LV-GLS| on post-PM echocardiogram showed a better
predictive value than did LVEF (AUC; 0.784 vs. 0.647, p= 0.012),
with acceptable sensitivity (60.9 %) and specificity (88.1%).
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TABLE 2 | Echocardiographic characteristics.
Total (n = 300) Without CV outcomes (n = 277) With CV outcomes (n = 23) P-value
Baseline echocardiogram
LVEDD, mm 50.3 ± 4.7 50.2 ± 4.6 51.4 ± 5.5 0.250
LVESD, mm 32.3 ± 4.3 32.2 ± 4.2 33.7 ± 5.4 0.120
LVEF. % 67.8 ± 6.8 67.9 ± 6.7 66.0 ± 7.5 0.191
LV mass index, g/m2 104.4 ± 22.5 103.8 ± 22.3 112.1 ± 25.0 0.130
LA volume index, ml/m2 35.8 ± 12.6 35.4 ± 12.5 40.4 ± 14.0 0.068
e’ velocity, cm/s 6.1 ± 2.4 6.2 ± 2.5 4.7 ± 1.5 0.012
S’ velocity, cm/s 6.7 ± 1.6 6.8 ± 1.6 5.8 ± 1.4 0.007
E/e’ 13.7 ± 6.3 13.3 ± 5.9 19.4 ± 8.7 0.007
|LV-GLS|, % 21.0 ± 5.3 21.2 ± 5.3 18.5 ± 4.7 0.016
|LV-GCS|, % 29.1 ± 7.0 29.2 ± 7.0 27.6 ± 6.8 0.292
Post-PM echocardiogram
Time after PM implantation, years 2.2 ± 1.2 2.2 ± 1.2 2.4 ± 1.4 0.730
LVEDD, mm 49.6 ± 5.1 49.4 ± 5.0 51.7 ± 6.2 0.035
LVESD, mm 33.4 ± 5.7 33.1 ± 5.5 36.4 ± 7.5 0.047
LVEF. % 62.2 ± 10.3 62.7 ± 9.7 55.1 ± 14.1 0.018
PMIC, n (%) 32 (10.7) 22 (7.9) 10 (43.5) <0.001
LV mass index, g/m2 101.4 ± 25.3 100.0 ± 24.6 120.0 ± 27.7 <0.001
LA volume index, ml/m2 34.8 ± 13.4 34.0 ± 12.9 44.8 ± 15.3 <0.001
e’ velocity, cm/s 5.3 ± 1.9 5.3 ± 1.9 5.0 ± 1.3 0.476
S’ velocity, cm/s 5.9 ± 1.4 5.9 ± 1.4 4.9 ± 0.9 <0.001
E/e’ 13.4 ± 5.9 13.0 ± 5.5 19.1 ± 8.4 0.007
Significant TR (≥grade 2) 18 (6.0) 17 (6.1) 1 (4.3) 0.728
|LV-GLS|, % 16.6 ± 5.3 17.0 ± 5.0 11.2 ± 5.5 <0.001
|LV-GCS|, % 24.5 ± 7.1 24.9 ± 6.9 19.1 ± 7.7 <0.001
CV, cardiovascular; LVEDD, left ventricular end-diastolic dimension; LVESD, left ventricular end-systolic dimension; LVEF, left ventricular ejection fraction; LV, left ventricle; LA, left atrium;
e’, early diastolic mitral annular tissue velocity; S’, systolic mitral annular tissue velocity; E/e’, ratio of early diastolic mitral inflow velocity to early diastolic mitral annular tissue velocity;
|LV-GLS|, absolute value of left ventricular global longitudinal strain; |LV-GCS|, absolute value of left ventricular global circumferential strain; PM, pacemaker; PMIC, pacemaker-induced
cardiomyopathy; TR, tricuspid regurgitation.
Figure 4 shows the Kaplan–Meier survival curves for the
two groups divided by an |LV-GLS| of 11.2 % and for three
subgroups divided by |LV-GLS| tertile. At a mean 44 ± 28
months of follow-up after post-PM echocardiogram, the lowest
|LV-GLS| group revealed a significantly worse CV outcome than
did the others (log-rank p < 0.001). In multivariate nested
Cox proportional hazard models, the lower |LV-GLS| showed
an independent association with poor CV outcomes in age and
sex adjusted analysis (hazard ratio, HR: 14.8; 95% confidence
interval, CI: 1.93–112.70, p = 0.009). Multivariate models
including comorbidities and conventional echocardiographic
variables also revealed that the lower |LV-GLS| had a statistically
significant association with poor CV outcomes (Model 2; HR:
15.18; CI: 1.96–117.61; p = 0.009) (Model 3; HR: 13.97; CI:
1.72–113.39; p= 0.014) (Table 4).
DISCUSSION
The principal findings of the present study were as follows: (1)
RV pacing deteriorated global and segmental LV mechanical
function, (2) |LV-GLS| at baseline echocardiogram showed a
good predictive value for PMIC after PM implantation, (3)
|LV-GLS| at post-PM echocardiogram revealed a better predictive
value of CV outcomes than did LVEF, and (4) reduced |LV-GLS|
was independently associated with poor CV outcomes in patients
with permanent PM. These results imply that, for patients who
undergo permanent PM implantation, serial assessments of LV-
GLS by speckle-tracking echocardiography before and after PM
implantation are beneficial for early detection of PMIC and
prediction of clinical outcomes.
Usefulness of LV-GLS in Patients Who
Underwent PM Implantation
As the population ages, not only is the number of patients
receiving permanent PM implantation increasing, but so is the
occurrence of heart failure after PM implantation. (20, 21).
PMIC has emerged as one of the most important complications
of PM implantation, and its incidence is increasing, increasing
the need to upgrade to cardiac resynchronization therapy (4).
PMIC is usually defined as a decrease of LVEF, but there
are many limitations in predicting PMIC before LV systolic
dysfunction. The present study demonstrated that the cut-off
value of 21.4 % in |LV-GLS| on baseline echocardiogram before
PM implantation revealed a significant predictive value for
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TABLE 3 | Simple correlations between pacing percentage and




LVEDD, mm 0.162 0.005
LVESD, mm 0.189 0.001
LVEF. % −0.210 <0.001
LV mass index, g/m2 0.116 0.048
LA volume index, ml/m2 0.100 0.083
e’ velocity, cm/s −0.138 0.021
S’ velocity, cm/s −0.202 0.001
E/e’ 0.013 0.833
|LV-GLS|, % −0.257 <0.001
|LV-GCS|, % −0.198 0.001
LV segmental longitudinal strain
















LVEDD, left ventricular end-diastolic dimension; LVESD, left ventricular end-systolic
dimension; LVEF, left ventricular ejection fraction; LV, left ventricle; LA, left atrium; e’, early
diastolic mitral annular tissue velocity; S’, systolic mitral annular tissue velocity; E/e’, ratio
of early diastolic mitral inflow velocity to early diastolic mitral annular tissue velocity; |LV-
GLS|, absolute value of left ventricular global longitudinal strain; |LV-GCS|, absolute value
of left ventricular global circumferential strain.
occurrence of PMIC after PM implantation, but LVEF did not.
In a previous study, Ahmed et al. showed changes in |LV-GLS|
and LVEF after PM implantation in 55 patients. (22) 1 month
after PM implantation, |LV-GLS| was significantly reduced from
16.3 ± 0.5 to 12.6 ± 0.9% in patients with PMIC compared
to baseline. At 12 months of follow-up, |LV-GLS| impairment
was reported as 11.9 ± 2.5%. This showed the sensitivity of LV-
GLS in predicting the development of PMIC. However, the study
included a small cohort of 55 patients, and the follow-up periods
were relatively short for estimating CV outcomes. Moreover,
LV-GLS was evaluated 1 month after PM implantation, and
additional echocardiographic studies are required. On the other
hand, the present study showed the predictive value of LV-GLS
in the occurrence of PMIC, and this was assessed before PM
implantation in a relatively large number of patients. In another
study, Babu et al. demonstrated that 3D echocardiography with
|LV-GLS| analysis played a role in predicting PMIC in a total of 36
FIGURE 2 | The changes in LVEF and |LV-GLS| according to CV outcomes on
baseline and post-PM echocardiogram. (A) LVEF decreased after PM
implantation in both groups, but the mean values were within the normal range
(red dotted line) even in patients with CV outcomes. (B) |LV-GLS| in patients
with CV outcomes decreased more noticeably than in patients without CV
outcomes under normal values (red dotted line). LVEF, left ventricular ejection
fraction; CV, cardiovascular; |LV-GLS|, absolute value of left ventricular global
longitudinal strain; PM, pacemaker.
patients (23). A decline in |LV-GLS| of 18.0% to 13.9% was noted
at 6-months after PM implantation, whereas a decline in LVEF
of 57.8% to 54.5% was noted after PM implantation. This study
was conducted in a small population of 36 patients with short
follow-up periods. Accordingly, the present study demonstrates
the usefulness of LV-GLS for predicting PMIC occurrence and
clinical outcome in patients with both baseline and post-PM
echocardiography and sufficient regular clinical follow-up for an
average of 44 months after post-PM echocardiography.
Pacing Percentage and LV Mechanical
Dysfunction
It is well known that the incidence of heart failure in patients
who underwent PM implantation is associated with RV pacing,
and that a higher RV pacing percentage results in a higher
incidence of CV events (24). In this study, it was confirmed that,
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FIGURE 3 | Predictive values of |LV-GLS| and LVEF for occurrence of PMIC and CV outcome. (A) The |LV-GLS| on baseline echocardiogram revealed significant
predictive value for occurrence of PMIC. (B) The |LV-GLS| on post-PM echocardiogram showed a better predictive value for CV outcomes than did LVEF. |LV-GLS|,
absolute value of left ventricular global longitudinal strain; LVEF, left ventricular ejection fraction; PMIC, pacemaker-induced cardiomyopathy; PM, pacemaker; CV,
cardiovascular.
FIGURE 4 | Kaplan–Meier curve according to |LV-GLS| on post-PM echocardiogram. (A) The group of |LV-GLS| ≤ 11.2% revealed a significantly worse CV outcome
than the other group (log-rank p < 0.001). (B) The lowest |LV-GLS| group revealed a significantly worse CV outcome than the others (log-rank p < 0.001). |LV-GLS|,
absolute value of left ventricular global longitudinal strain; PM, pacemaker; CV, cardiovascular.
as RV pacing percentage increased, the global LV mechanical
function evaluated by |LV-GLS| decreased, and it was more
obvious when the analysis was performed divided by RV
pacing site. Previous studies also tried to show the relationship
between pacing percentage and LV-GLS; however, mainly due
to the small number of study subjects, they failed to show
a linear correlation (22, 25). Another strength of the present
study is that it comprehensively shows LV regional mechanical
dysfunction by pacing through segmental strain analysis. As
pacing percentage increased, the absolute value of longitudinal
strain in some specific segments decreased. The specific segments
that were highly affected by pacing were those in the entire
LV apex. The correlation weakened toward the mid-LV and
base, but the absolute value of segmental strain in the inferior
segment and infero-septal segment significantly decreased in
proportion to pacing percentage. These results can be interpreted
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TABLE 4 | Cox regression analysis for CV outcomes.
Model 1 Model 2 Model 3
Hazard ratio [95% CI] P-value Hazard ratio [95% CI] P-value Hazard ratio [95% CI] P-value
|LV-GLS| > 19.1% Reference Reference Reference
14.4 < |LV-GLS| ≤ 19.1% 5.80 [0.68∼49.84] 0.109 4.06 [0.46∼35.66] 0.207 4.59 [0.52∼40.13] 0.169
|LV-GLS| ≤ 14.4% 14.8 [1.93∼112.70] 0.009 15.18 [1.96∼117.61] 0.009 13.97 [1.72∼113.39] 0.014
Model 1: Adjusted by age and sex.
Model 2: Adjusted by age, sex, CKD, and CAD.
Model 3: Adjusted by age, sex, CKD, CAD, LVEF, and LA volume index.
CI, confidence interval; CKD, chronic kidney disease; CAD, coronary artery disease; LVEF, left ventricular ejection fraction; LA, left atrium; |LV-GLS|, absolute value of left ventricular
global circumferential strain.
based on the pathophysiology of PMIC. During RV pacing,
conduction of an electrical wave passes through the myocardium,
which is adjacent to the PM lead (6, 26). Therefore, there
were significant decreases in strain in the regions close to the
pacing area (27). This phenomenon results in dyssynchronous
motion of LV. In patients with dyssynchronous motion due
to higher RV pacing burden and subsequent lower LVEF, an
upgrade from PM to cardiac resynchronization therapy might
be considered to improve LV mechanical dysfunction and to
treat heart failure (5). Considering the cut-off value of |LV-
GLS| of post-PM implantation as 11.2%, patients with |LV-
GLS| under 11.2% on post-PM implantation echocardiography
are recommended to adjust the PM pacing parameters to
reduce the pacing percentage or consider to converse to
cardiac resynchronization therapy, with aggressive heart failure
medication. In patients with |LV-GLS| in the gray zone between
11.2 to 20%, regular echocardiography follow-up to identify
whether |LV-GLS| decreases under 11.2% andmanage several risk
factors regarding heart failure are required.
Limitations
This study has several limitations. First, this study was
retrospectively designed and comprised patients who were
followed up by regular visits. The interval of follow-up
echocardiogram after PM implantation was not concordant in
all patients. To minimize this limitation, the timing of follow-up
echocardiogram was limited to between 6 months and 5 years
after PM implantation to evaluate the predictability of future
CV events of LV-GLS. Nevertheless, the population might be
biased, and it is possible that the occurrence of clinical events
was underestimated. Second, echocardiographic examinations
of patients were not performed using the same equipment,
which could have produced inconsistency of echocardiographic
parameters, especially LV-GLS. However, we used vendor-
independent software and tried to minimize the error of
measurement by expert operators. Third, the |LV-GLS| value for
predicting PMIC on the baseline echocardiogram before PM
implantation was 21.4%, which was within the normal range.
According to previous results of a head-to-head comparison of
LV-GLS among vendors reported by the European Association of
Cardiovascular Imaging/American Society of Echocardiography,
the average |LV-GLS| values measured by TomTec software
was 21.5%, trending higher than other software measures. (28).
Also, there is a possibility that |LV-GLS| was high because of a
compensatory increase in stroke volume due to bradycardia in
some patients. As a result, we suggest that, if |LV-GLS| is lower
than the normal reference value before PM implantation, close
clinical and echocardiographic follow-up should be performed
after PM implantation considering the risk of PMIC.
CONCLUSION
After PM implantation, there were significant regional and
global changes in LV mechanical function. On post-PM
echocardiogram, reduced |LV-GLS| rather than LVEF is
associated with poor CV outcome. Assessments of LV-GLS
by speckle-tracking echocardiography before and after PM
implantation are beneficial for early detection of LV mechanical
dysfunction and prediction of CV outcomes.
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